Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan.

Chou YC, Lee MS, Wu MH, Shih HL, Yang T, Yu CP, Yu JC, Sun CA.

Breast Cancer Res Treat. 2007 Jan;101(2):199-205. Epub 2006 Jul 19.

PMID:
16850249
2.

Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.

Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C.

Eur Heart J. 2009 Jan;30(1):6-15. doi: 10.1093/eurheartj/ehn515. Epub 2008 Nov 23. Review.

PMID:
19029125
3.

Menopause, the cardiovascular risk factor homocysteine, and the effects of treatment.

De Leo V, la Marca A, Morgante G, Musacchio MC, Luisi S, Petraglia F.

Treat Endocrinol. 2004;3(6):393-400. Review.

PMID:
15511133
4.

Homocysteine and vitamin therapy in stroke prevention and treatment: a review.

Manolescu BN, Oprea E, Farcasanu IC, Berteanu M, Cercasov C.

Acta Biochim Pol. 2010;57(4):467-77. Epub 2010 Dec 6. Review.

5.

Relationship of homocysteine with cardiovascular disease and blood pressure.

Dinavahi R, Falkner B.

J Clin Hypertens (Greenwich). 2004 Sep;6(9):494-8; quiz 499-500. Review.

6.

Role of vitamins in the risk, prevention, and treatment of breast cancer.

Zhang SM.

Curr Opin Obstet Gynecol. 2004 Feb;16(1):19-25. Review.

PMID:
15128003
7.

Homocysteine level and risk of fracture: A meta-analysis and systematic review.

Yang J, Hu X, Zhang Q, Cao H, Wang J, Liu B.

Bone. 2012 Sep;51(3):376-82. doi: 10.1016/j.bone.2012.05.024. Epub 2012 Jun 26. Review.

PMID:
22749888
8.

Molecular basis of homocysteine toxicity in humans.

Jakubowski H.

Cell Mol Life Sci. 2004 Feb;61(4):470-87. Review.

PMID:
14999406

Supplemental Content

Support Center